{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:53:34Z","timestamp":1791345214846,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.plefa.2005.05.012","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T17:13:09Z","timestamp":1119978789000},"page":"245-250","source":"Crossref","is-referenced-by-count":38,"title":["Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs"],"prefix":"10.1016","volume":"73","author":[{"given":"William J.","family":"Guilford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2005.05.012_bib1","series-title":"Advances in Rheumatology and Inflammation","first-page":"141","author":"Serhan","year":"1991"},{"key":"10.1016\/j.plefa.2005.05.012_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI13375","article-title":"Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways","volume":"107","author":"Serhan","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.05.012_bib3","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/jm030569l","article-title":"Novel 3-oxa lipoxin A4 analogs with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo","volume":"47","author":"Guilford","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.plefa.2005.05.012_bib4","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M002863200","article-title":"Oxidoreductases in lipoxin A4 metabolic inactivation: 15-oxaprostaglandin 13-reductase\/leukotriene B4 12-hydroxydehydrogenase is a multifunctional eicosanoid oxidoreductase","volume":"33","author":"Clish","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.05.012_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4","volume":"8","author":"Levy","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.plefa.2005.05.012_bib6","first-page":"7064","article-title":"An aspirin-triggered lipoxinA4 stable analog displays a unique topical anti-inflammatory profile","volume":"168","author":"Schottelius","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2005.05.012_bib7","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.4049\/jimmunol.168.10.5260","article-title":"Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis","volume":"168","author":"Gewirtz","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2005.05.012_bib8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20021183","article-title":"Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection","volume":"196","author":"Aliberti","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2005.05.012_bib9","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.96.14.8247","article-title":"Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo","volume":"96","author":"Clish","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.05.012_bib10","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/S0021-9258(18)50709-2","article-title":"Metabolism of prostaglandin D2 in the monkey","volume":"254","author":"Ellis","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.05.012_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0090-6980(86)90228-5","article-title":"Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat","volume":"31","author":"Sturzebecher","year":"1986","journal-title":"Prostaglandins"},{"key":"10.1016\/j.plefa.2005.05.012_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/jo00237a008","article-title":"Total synthesis of LTB4 and analogues","volume":"53","author":"Guindon","year":"1988","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.plefa.2005.05.012_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/jm00153a001","article-title":"Synthesis of a new chemically and metabolically stable prostacyclin analogue with high and long-lasting oral activity","volume":"29","author":"Skuballa","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.plefa.2005.05.012_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-291X(84)91486-4","article-title":"Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes","volume":"118","author":"Serhan","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.05.012_bib15","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/S0040-4039(01)81500-8","article-title":"Synthesis of lipoxins: total synthesis of conjugated trihydroxy eicosatetraenoic acids","volume":"25","author":"Adams","year":"1984","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.plefa.2005.05.012_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0040-4039(01)80797-8","article-title":"Simple synthesis and assignment of stereochemistry of lipoxin A","volume":"26","author":"Corey","year":"1985","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.plefa.2005.05.012_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1039\/c39850000297","article-title":"A general strategy for the total synthesis of the presumed lipoxin structures","author":"Nicolaou","year":"1985","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.plefa.2005.05.012_bib18","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/S0040-4039(01)01187-X","article-title":"Total synthesis of aspirin-triggered 15-epi-lipoxin A4","volume":"42","author":"Rodriguez","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.plefa.2005.05.012_bib19","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0960-894X(03)00667-X","article-title":"Synthesis of methyl (5R, 6R, 7E, 9E, 11Z, 13E, 15S)-16-(4-fluorophenoxy)-5,6,15-trihydroxy-7, 9, 11, 13-hexadecatetraenoate, an analogue of 15R-Lipoxin A4","author":"Phillips","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.plefa.2005.05.012_bib20","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.1021\/ja00311a048","article-title":"Stereocontrolled total synthesis of lipoxins A","volume":"107","author":"Nicolaou","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.plefa.2005.05.012_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4","volume":"101","author":"Takano","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.05.012_bib23","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.189.12.1923","article-title":"Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis","volume":"189","author":"Hachicha","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2005.05.012_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-4793-8_42","article-title":"Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues inhibit neutrophil-mediated changes in vascular permeability","volume":"469","author":"Serhan","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.plefa.2005.05.012_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.bjp.0705912","article-title":"Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration","volume":"143","author":"Bannenberg","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2005.05.012_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI7016","article-title":"Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion","volume":"104","author":"Chiang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.05.012_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.185.9.1693","article-title":"Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors","volume":"185","author":"Takano","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2005.05.012_bib28","doi-asserted-by":"crossref","first-page":"16340","DOI":"10.1016\/S0021-9258(18)66571-8","article-title":"Lipoxin A. Stereochemistry and biosynthesis","volume":"261","author":"Serhan","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.05.012_bib29","doi-asserted-by":"crossref","unstructured":"L. Simchowitz, S. Fiore, C.N. Serhan, Carrier-mediated transport of lipoxin A4 in human neutrophils, Am. J. Physiol. 267 (1994) C1525\u20131534.","DOI":"10.1152\/ajpcell.1994.267.6.C1525"},{"key":"10.1016\/j.plefa.2005.05.012_bib30","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1073\/pnas.0404722101","article-title":"A \u03b2-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction","volume":"101","author":"Fiorucci","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327805000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327805000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T15:32:00Z","timestamp":1626103920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327805000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":29,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0952327805000906"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2005.05.012","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}